Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.
暂无分享,去创建一个
D. Gladman | L. Magder | B. Rovin | C. Gordon | K. Kalunian | O. Nived | M. Petri | J. Sánchez-Guerrero | M. Urowitz | G. Alarcón | D. Fine | D. Adu | S. Bae | G. Sturfelt | J. Buyon | S. Bernatsky | M. Madaio | K. Steinsson | M. Khamashta | D. Wallace | J. Merrill | R. Ramsey‐Goldman | A. Clarke | R. V. van Vollenhoven | J. Balow | J. Hanly | T. Stoll | G. Contreras | C. Aranow | E. Ginzler | M. Dooley | C. Ávila-Casado | A. Zoma | N. Kasitanon | J. Tumlin | Kimberly Link | J. Font | I. Bruce | Sukminder Singh | C. Avila-Casado
[1] L. Magder,et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis , 2006, Lupus.
[2] R. Burt,et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. , 2006, JAMA.
[3] Mimi Y. Kim,et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. , 2005, The New England journal of medicine.
[4] D A Isenberg,et al. Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus , 2005 .
[5] P. Mathieson,et al. Mycophenolate Mofetil for Remission Induction in Severe Lupus Nephritis , 2005, Nephron Clinical Practice.
[6] J. Tumlin,et al. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. , 2004, Seminars in nephrology.
[7] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.
[8] J. Forslid,et al. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. , 2002, The Journal of rheumatology.
[9] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[10] D. Isenberg,et al. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. , 1996, Annals of the rheumatic diseases.
[11] D A Isenberg,et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.
[12] H. Sakaguchi. [Classification of glomerular diseases--autopsy and biopsy of the kidney]. , 1984, Nihon rinsho. Japanese journal of clinical medicine.
[13] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[14] Ruddle Fh,et al. Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6. , 1976, Cytogenetics and cell genetics.